Compared with T2DM control mice, the levels of body weight and fasting blood glucose significantly declined, whereas fasting insulin levels were obviously elevated in TG-treated groups in a dose-dependent manner (Fig. 4A-C). The gene discussed is INS; the disease is type 2 diabetes mellitus.